Your browser doesn't support javascript.
loading
HER2-positive metastatic breast cancer: a changing scenario.
Mustacchi, G; Biganzoli, L; Pronzato, P; Montemurro, F; Dambrosio, M; Minelli, M; Molteni, L; Scaltriti, L.
Affiliation
  • Mustacchi G; Medical Oncology, Department of Medical Sciences, University of Trieste, Italy. Electronic address: gmustacchi@units.it.
  • Biganzoli L; Department of Oncology, New Hospital of Prato, Italy.
  • Pronzato P; Department of Oncology, San Martino Hospital and National Institute for Cancer Research, Genova, Italy.
  • Montemurro F; Department of Oncology, Institute for Cancer Research and Treatment, Candiolo (TO), Italy.
  • Dambrosio M; Department of Oncology, Multimedica, Sesto San Giovanni (MI), Italy.
  • Minelli M; Department of Oncology, S. Eugenio Hospital, Roma, Italy.
  • Molteni L; Department of Oncology, Multimedica, Castellanza (VA), Italy.
  • Scaltriti L; Department of Oncology, Civil Hospital, Guastalla (MN), Italy.
Crit Rev Oncol Hematol ; 95(1): 78-87, 2015 Jul.
Article in En | MEDLINE | ID: mdl-25748080

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Brain Neoplasms / Breast Neoplasms / Antineoplastic Combined Chemotherapy Protocols / Receptor, ErbB-2 Type of study: Observational_studies Limits: Female / Humans Language: En Journal: Crit Rev Oncol Hematol Journal subject: HEMATOLOGIA / NEOPLASIAS Year: 2015 Document type: Article

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Brain Neoplasms / Breast Neoplasms / Antineoplastic Combined Chemotherapy Protocols / Receptor, ErbB-2 Type of study: Observational_studies Limits: Female / Humans Language: En Journal: Crit Rev Oncol Hematol Journal subject: HEMATOLOGIA / NEOPLASIAS Year: 2015 Document type: Article